Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy – Detecting Illusive Disease, Defining Response
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy – Detecting Illusive Disease, Defining Response
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-02-23
DOI
10.3389/fneur.2015.00033
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of magnetic resonance spectroscopy for the differentiation of recurrent glioma from radiation necrosis: A systematic review and meta-analysis
- (2014) Hui Zhang et al. EUROPEAN JOURNAL OF RADIOLOGY
- Antigen-Specific Immune Responses and Clinical Outcome After Vaccination With Glioma-Associated Antigen Peptides and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Children With Newly Diagnosed Malignant Brainstem and Nonbrainstem Gliomas
- (2014) Ian F. Pollack et al. JOURNAL OF CLINICAL ONCOLOGY
- Histogram analysis of apparent diffusion coefficient within enhancing and nonenhancing tumor volumes in recurrent glioblastoma patients treated with bevacizumab
- (2014) Rifaquat Rahman et al. JOURNAL OF NEURO-ONCOLOGY
- Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
- (2014) Walter Taal et al. LANCET ONCOLOGY
- Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD)
- (2014) Patrick Y. Wen et al. NEURO-ONCOLOGY
- MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy
- (2014) Shahrzad Jalali et al. NEURO-ONCOLOGY
- Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma
- (2014) K. M. Schmainda et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Clinical Proton MR Spectroscopy in Central Nervous System Disorders
- (2014) Gülin Öz et al. RADIOLOGY
- Which Combination of MR Imaging Modalities Is Best for Predicting Recurrent Glioblastoma? Study of Diagnostic Accuracy and Reproducibility
- (2014) Ho Sung Kim et al. RADIOLOGY
- Standards of care and novel approaches in the management of glioblastoma multiforme
- (2014) Andreas F. Hottinger et al. Chinese Journal of Cancer
- Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging
- (2013) Young Jun Choi et al. ACTA RADIOLOGICA
- Arterial Spin-Labeling Assessment of Normalized Vascular Intratumoral Signal Intensity as a Predictor of Histologic Grade of Astrocytic Neoplasms
- (2013) J. Furtner et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Assessment of Early Therapy Response with 18F-FLT PET in Glioblastoma Multiforme
- (2013) Matthew J. Oborski et al. CLINICAL NUCLEAR MEDICINE
- Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival
- (2013) E. Hattingen et al. NEURO-ONCOLOGY
- Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
- (2013) T. T. Batchelor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recurrent Glioblastoma Treated with Bevacizumab: Contrast-enhanced T1-weighted Subtraction Maps Improve Tumor Delineation and Aid Prediction of Survival in a Multicenter Clinical Trial
- (2013) Benjamin M. Ellingson et al. RADIOLOGY
- Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study
- (2012) Whitney B. Pope et al. JOURNAL OF NEURO-ONCOLOGY
- Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-L-Tyrosine PET in Comparison to MRI
- (2012) N. Galldiks et al. JOURNAL OF NUCLEAR MEDICINE
- Performance of 18F-Fluoro-Ethyl-Tyrosine (18F-FET) PET for the Differential Diagnosis of Primary Brain Tumor: A Systematic Review and Metaanalysis
- (2012) V. Dunet et al. JOURNAL OF NUCLEAR MEDICINE
- Quantitative probabilistic functional diffusion mapping in newly diagnosed glioblastoma treated with radiochemotherapy
- (2012) B. M. Ellingson et al. NEURO-ONCOLOGY
- Temporal changes in magnetic resonance imaging characteristics of Gliadel wafers and of the adjacent brain parenchyma
- (2012) S. Ulmer et al. NEURO-ONCOLOGY
- Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma
- (2012) B. M. Ellingson et al. NEURO-ONCOLOGY
- Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival
- (2012) L. S. Hu et al. NEURO-ONCOLOGY
- Evaluation of dynamic contrast-enhanced T1-weighted perfusion MRI in the differentiation of tumor recurrence from radiation necrosis
- (2012) Vibeke A. Larsen et al. NEURORADIOLOGY
- Percent Change of Perfusion Skewness and Kurtosis: A Potential Imaging Biomarker for Early Treatment Response in Patients with Newly Diagnosed Glioblastomas
- (2012) Hye Jin Baek et al. RADIOLOGY
- Pseudoprogression of Glioblastoma after Chemo- and Radiation Therapy: Diagnosis by Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging with Ferumoxytol versus Gadoteridol and Correlation with Survival
- (2012) Seymur Gahramanov et al. RADIOLOGY
- Distinguishing Recurrent High-grade Gliomas from Radiation Injury
- (2011) Sotirios Bisdas et al. ACADEMIC RADIOLOGY
- Does MR Perfusion Imaging Impact Management Decisions for Patients with Brain Tumors? A Prospective Study
- (2011) C.P. Geer et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Advantages of high b-value diffusion-weighted imaging to diagnose pseudo-responses in patients with recurrent glioma after bevacizumab treatment
- (2011) Fumiyuki Yamasaki et al. EUROPEAN JOURNAL OF RADIOLOGY
- Do we need novel radiologic response criteria for brain tumor immunotherapy?
- (2011) Hideho Okada et al. Expert Review of Neurotherapeutics
- T1- and T*2-Dominant Extravasation Correction in DSC-MRI: Part I—Theoretical Considerations and Implications for Assessment of Tumor Hemodynamic Properties
- (2011) Atle Bjornerud et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- T1- and T2*-Dominant Extravasation Correction in DSC-MRI: Part II—Predicting Patient Outcome after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
- (2011) Kyrre E Emblem et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab
- (2011) Benjamin M. Ellingson et al. JOURNAL OF NEURO-ONCOLOGY
- Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab
- (2011) B. M. Ellingson et al. NEURO-ONCOLOGY
- Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion
- (2011) J. Narang et al. NEURO-ONCOLOGY
- A Novel Method for Volumetric MRI Response Assessment of Enhancing Brain Tumors
- (2011) Charles W. Kanaly et al. PLoS One
- Gliomas: Histogram Analysis of Apparent Diffusion Coefficient Maps with Standard- or High-b-Value Diffusion-weighted MR Imaging—Correlation with Tumor Grade
- (2011) Yusuhn Kang et al. RADIOLOGY
- The first 3 months after BCNU wafers implantation in high-grade glioma patients: clinical and radiological considerations on a clinical series
- (2010) Alessandro Della Puppa et al. ACTA NEUROCHIRURGICA
- In Vivo Correlation of Tumor Blood Volume and Permeability with Histologic and Molecular Angiogenic Markers in Gliomas
- (2010) R. Jain et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: Assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI
- (2010) Yong Hwy Kim et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Prognostic Value of Early [18F]Fluoroethyltyrosine Positron Emission Tomography After Radiochemotherapy in Glioblastoma Multiforme
- (2010) Marc D. Piroth et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Parametric Response Map As an Imaging Biomarker to Distinguish Progression From Pseudoprogression in High-Grade Glioma
- (2010) Christina Tsien et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
- (2010) Tracy T. Batchelor et al. JOURNAL OF CLINICAL ONCOLOGY
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity
- (2010) Benjamin M. Ellingson et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis
- (2010) Laura L. Horky et al. JOURNAL OF NEURO-ONCOLOGY
- Kinetics of 3'-Deoxy-3'-18F-Fluorothymidine During Treatment Monitoring of Recurrent High-Grade Glioma
- (2010) C. Schiepers et al. JOURNAL OF NUCLEAR MEDICINE
- Correlation of 6-18F-Fluoro-L-Dopa PET Uptake with Proliferation and Tumor Grade in Newly Diagnosed and Recurrent Gliomas
- (2010) B. J. Fueger et al. JOURNAL OF NUCLEAR MEDICINE
- Spatially quantifying microscopic tumor invasion and proliferation using a voxel-wise solution to a glioma growth model and serial diffusion MRI
- (2010) Benjamin M. Ellingson et al. MAGNETIC RESONANCE IN MEDICINE
- Standardization of relative cerebral blood volume (rCBV) image maps for ease of both inter- and intrapatient comparisons
- (2010) Devyani Bedekar et al. MAGNETIC RESONANCE IN MEDICINE
- Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma
- (2010) E. Essock-Burns et al. NEURO-ONCOLOGY
- ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma
- (2010) Martha Nowosielski et al. NEURORADIOLOGY
- MR perfusion and diffusion imaging in the follow-up of recurrent glioblastoma treated with dendritic cell immunotherapy: a pilot study
- (2010) Matej Vrabec et al. NEURORADIOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Changes in Relative Cerebral Blood Volume 1 Month after Radiation-Temozolomide Therapy Can Help Predict Overall Survival in Patients with Glioblastoma
- (2010) Rajiv Mangla et al. RADIOLOGY
- An Automatic Procedure for Normalization of Cerebral Blood Volume Maps in Dynamic Susceptibility Contrast−Based Glioma Imaging
- (2009) K.E. Emblem et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Optimized Preload Leakage-Correction Methods to Improve the Diagnostic Accuracy of Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging in Posttreatment Gliomas
- (2009) L.S. Hu et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Developing a Clinical Decision Model: MR Spectroscopy to Differentiate Between Recurrent Tumor and Radiation Change in Patients with New Contrast-Enhancing Lesions
- (2009) Ethan A. Smith et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
- (2009) A. Gregory Sorensen et al. CANCER RESEARCH
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas
- (2009) R. Prat et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Phase I/II Trial of Tremelimumab in Patients With Metastatic Melanoma
- (2009) Luis H. Camacho et al. JOURNAL OF CLINICAL ONCOLOGY
- End Point Assessment in Gliomas: Novel Treatments Limit Usefulness of Classical Macdonald's Criteria
- (2009) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Imaging response criteria for recurrent gliomas treated with bevacizumab: Role of diffusion weighted imaging as an imaging biomarker
- (2009) Rajan Jain et al. JOURNAL OF NEURO-ONCOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy of 3′-Deoxy-3′-[18F]fluorothymidine (FLT) as a Marker of Proliferation in Patients with Recurrent Gliomas: Preliminary Efficacy Studies
- (2009) Alexander M. Spence et al. MOLECULAR IMAGING AND BIOLOGY
- Distinction between glioma progression and post-radiation change by combined physiologic MR imaging
- (2009) Eiji Matsusue et al. NEURORADIOLOGY
- Distinguishing Glioma Recurrence from Treatment Effect After Radiochemotherapy and Immunotherapy
- (2009) Isaac Yang et al. NEUROSURGERY CLINICS OF NORTH AMERICA
- Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment
- (2009) Whitney B. Pope et al. RADIOLOGY
- Grading Astrocytic Tumors by Using Apparent Diffusion Coefficient Parameters: Superiority of a One- versus Two-Parameter Pilot Method
- (2009) Ryuji Murakami et al. RADIOLOGY
- Differentiation of Recurrent Glioblastoma Multiforme from Radiation Necrosis after External Beam Radiation Therapy with Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging
- (2009) Ramon F. Barajas et al. RADIOLOGY
- Analysis of11C-methionine Uptake in Low-Grade Gliomas and Correlation with Proliferative Activity
- (2008) T. Kato et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements
- (2008) L.S. Hu et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- 18F-FDG PET of Common Enhancing Malignant Brain Tumors
- (2008) Nobuyuki Kosaka et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Glioma Proliferation as Assessed by 3'-Fluoro-3'-Deoxy-L-Thymidine Positron Emission Tomography in Patients with Newly Diagnosed High-Grade Glioma
- (2008) R. Ullrich et al. CLINICAL CANCER RESEARCH
- Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence
- (2008) Manuel Gómez-Río et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: Initial experience
- (2008) Carlos J. Ledezma et al. EUROPEAN JOURNAL OF RADIOLOGY
- Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma
- (2008) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma
- (2008) Andrew D. Norden et al. JOURNAL OF NEURO-ONCOLOGY
- Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
- (2008) Dieta Brandsma et al. LANCET ONCOLOGY
- Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas
- (2008) Kathleen R. Lamborn et al. NEURO-ONCOLOGY
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of Dynamic Susceptibility-weighted Contrast-enhanced MR Methods: Recommendations for Measuring Relative Cerebral Blood Volume in Brain Tumors
- (2008) Eric S. Paulson et al. RADIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More